Verition Fund Management’s Enfusion, Inc. ENFN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-20,440
Closed -$228K 3954
2025
Q1
$228K Buy
20,440
+3,580
+21% +$39.6K ﹤0.01% 3000
2024
Q4
$174K Buy
+16,860
New +$163K ﹤0.01% 3008
2024
Q3
Sell
-14,869
Closed -$127K 3566
2024
Q2
$127K Sell
14,869
-19,339
-57% -$177K ﹤0.01% 2695
2024
Q1
$316K Buy
+34,208
New +$301K ﹤0.01% 2273

Other funds holding ENFN

Verition Fund Management's ENFN Position: Q2 2025 in Review

Verition Fund Management sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 20,440 shares — an estimated $228K sold.

Verition Fund Management first reported a position in ENFN in Q1 2024 and held it in 4 quarters. The position peaked at $316K in Q1 2024. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

  • Verition Fund Management reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
  • Verition Fund Management sold 20,440 Enfusion, Inc. shares in Q2 2025, an estimated $228K.
  • Verition Fund Management first reported a position in Enfusion, Inc. in Q1 2024 and held it in 4 quarters.
  • Verition Fund Management's Enfusion, Inc. position peaked at $316K in Q1 2024.
  • 2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on Verition Fund Management's 13F filing for Q2 2025, filed 14 Aug 2025.